Table 1 Sociodemographic and clinical characteristics for the pre-treatment

Age at diagnosis, mean (SD)

49.72 (10.80)

50 (40, 56)

50 (43, 57)

50 (43, 57)

Hospital

TASH

168 (45)

52 (62)

106 (63)

30 (21)

SPMMC

203 (55)

32 (38)

40 (27)

111 (79)

Age at first marriage

18 (16, 20)

18 (16, 20)

18 (16, 20)

20 (16, 22)

Number of children

4 (3, 7)

4 (2, 6)

5 (2, 7)

4 (2, 6)

Level of educational

Unable to read and write

157 (42.3)

34 (40.5)

77 (52.7)

46 (32.6)

Able to read and write

68 (18.3)

17 (20.2)

25 (17.3)

26 (18.4)

Primary school

86 (23.2)

19 (22.6)

31 (21.2)

36 (25.5)

Secondary school

45 (12.1)

11 (13.2)

11 (7.5)

23 (16.3)

Higher education

15 (4.1)

3 (3.50)

2 (1.4)

10 (7.1)

Marital status

Single

8 (2.2)

4 (4.8)

2 (1.4)

2 (1.4)

Married

277 (74.7)

60 (71)

101 (69)

116 (82)

Divorced

36 (9.7)

8 (9.5)

24 (16)

9 (6.4)

Widowed

50 (13.4)

12 (14)

14 (9.9)

Employment status

Employed

49 (13.2)

12 (14)

14 (9.6)

23 (16.3)

Unemployed

322 (86.8)

72 (86)

132 (90.4)

118 (83.7)

Place of residence

Addis Ababa

136 (36.7)

26 (31)

47 (32.2)

63 (44.7)

Out of Addis Ababa

235 (63.3)

58 (69)

99 (76.8)

78 (55.3)

Monthly household income

2000 (1000–3000)

2000 (1000–3000)

2000 (1000–4000)

2000 (1500–3000)

Insurance type

Not used

124 (33)

29 (35)

39 (26.7)

56 (39.7)

Private insurance

104 (28)

28 (33)

19 (13)

57 (40.4)

CBHI

143 (38)

27 (32)

87 (59.6)

28 (19.9)

Time since diagnosis

4 (3,7)

4 (3, 6)

4 (3, 8)

5 (3, 8)

Tumor stage

Not staged

3 (0.8)

3 (2.1)

Stage I

110 (29.6)

31 (37)

29 (20)

50 (35)

Stage II

158 (42.6)

28 (33)

64 (44)

66 (47)

Stage III

65 (17.5)

13 (15)

38 (26)

14 (9.9)

Stage IV

35 (9.4)

12 (14)

12 (8.2)

11 (7.8)

Treatment modalities

Not take treatment

6 (1.6)

Surgery alone

127 (34)

34 (40)

2 (1.4)

57 (40.7)

Chemotherapy

29 (7.8)

8 (9.5)

24 (16)

19 (13)

Radiotherapy

48 (13)

11 (13)

52 (36)

13 (9.2)

Chemoradiation

93 (25)

19 (23)

22 (16)

Surgery + adjuvant chemoradiation

5 (1.4)

-

-

4 (2.8)

Surgery + chemotherapy

69 (18. 6)

11 (13)

31 (21.7)

26 (18)

Chemotherapy regimen

Carboplatin + Paclitaxel

65 (18)

15 (18)

34 (23)

16 (11)

Cisplatin + Paclitaxel

53 (14)

10 (12)

26 (18)

17 (12)

Chemotherapy cycle

Cycle 1

143 (38)

32 (38)

62 (42)

47 (33)

Cycle 2

1 (0.3)

Cycle 3

8 (2.2)

2 (2.4)

6 (4.1)

Cycle 6

2 (0.5)

1 (0.7)

1 (0.7)

Comorbidity

No

249 (67.1)

53 (63)

100 (68)

97 (69)

Yes

122 (32.9)

31 (37)

44 (31)

Type of comorbidity

HTN

30 (8.1)

8 (9.5)

10 (6.8)

12 (8.5)

HIV/AIDS

67 (18.1)

18 (21)

24 (16)

25 (18)

Diabetes

5 (1.3)

1 (1.2)

3 (2.1)

2 (1.4)

Diabetes + HTN

5 (1.3)

1 (1.2)

3 (2.1)

-

HIV/AIDS + HTN

15 (12.5)

3 (3.6)

3 (2.1)

2 (1.4)

Number of comorbidities

1

105 (28.3)

25 (30)

40 (27)

2

14 (3.8)

5 (6.0)

5 (3.4)

40 (28)

4

3 (0.9)

1 (1.2)

4 (2.8)

ECOG-performance

1

298 (80)

66 (79)

112 (77)

120 (85)

2

67 (18)

17 (20)

30 (21)

20 (14)

3

2 (0.5)

1 (1.2)

1 (0.7)

Cigarette smoking

No

371 (100)

84 (100)

146 (100)

141 (100)

Yes

-

-

-

Alcohol habit

No

363 (97.8)

83 (99)

140 (95.9)

140 (99.3)

Yes

8 (2.2)

1 (1)

6 (4.1)

1 (0.7)

Chat chewing habit

No

366 (98.7)

84 (100)

142 (97.3)

140 (99.3)

Yes

5 (1.3)

4(2.7)

1 (0.7)